英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Shrieked查看　Shrieked　在百度字典中的解释百度英翻中〔查看〕
Shrieked查看　Shrieked　在Google字典中的解释Google英翻中〔查看〕
Shrieked查看　Shrieked　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • MAR-T Cell Technology - Marker Therapeutics, Inc.
    Leveraging millions of years of immunologic evolution, Marker’s unique Multi-Antigen Recognizing T cell (MAR-T cell) technology utilizes a non-genetically modified cell therapy approach that selectively expands natural tumor-specific T cells from a patient’s blood that are capable of recognizing a broad range of tumor antigens Unlike other cell therapies, MAR-T cells allow the recognition
  • Our Company - Marker Therapeutics, Inc.
    Marker Therapeutics is dedicated to the development and commercialization of next-generation T cell-based immunotherapies for patients with a wide range of blood cancers and solid tumors Our team is comprised of talented and passionate professionals with deep expertise in cancer immunotherapy and driven by an urgency to deliver effective treatments to patients who currently have few or no
  • » Management - Marker Therapeutics, Inc.
    Dr Vera is a co-founder of Marker Therapeutics, and he has previously collaborated with Celgene and Bluebird Bio in developing novel CAR T cell therapies
  • Active Clinical Trials - Marker Therapeutics, Inc.
    Based on positive results of previous MAR-T cell product candidates in various blood cancers and solid tumors, we are currently investigating our lead product candidate, MT-601, in a Phase 1 multi-center clinical trial (APOLLO study) Our APOLLO study is enrolling patients with lymphoma who relapsed or are ineligible to receive anti-CD19 CAR-T cell therapy
  • Careers - Marker Therapeutics, Inc.
    Marker is always looking for talented, passionate people to join our team Located in the heart of Houston, TX, our team focuses on developing innovative cancer immunotherapies using our novel MAR-T cell technology Our employees are motivated by a common goal: to improve cancer treatments and improve the lives of patients If you are interested in joining our creative, collaborative team with
  • MAR-T Cell Pipeline - Marker Therapeutics, Inc.
    Our Company Our Company Management Board of Directors Scientific Advisory Board Contact Us Product Candidates Pipeline MAR-T Cell Therapies Our Science MAR-T Cell Technology Manufacturing Publications Clinical Trials Active Clinical Trials Expanded Access Policy Investors Media Investors Media Home News Events Stock Information Financials Filings Corporate Governance Investor Resources Careers
  • Marker Therapeutics, Inc.
    Marker Therapeutics Advancing Novel T-cell Therapies for Blood Cancers and Solid Tumors Harnessing millions of years of immunologic evolution, Marker’s Multi-Antigen Recognizing (MAR) T cell therapy is designed to recognize and kill highly heterogeneous tumors without the need for genetic modifications
  • MAR-T Cell Therapies - Marker Therapeutics, Inc.
    Marker uses a Multi-Antigen Recognizing T cell (MAR-T cell) technology that harnesses millions of years of immunological evolution intended to provide patients with T cells capable of recognizing multiple antigens within a tumor, with the expectation of reducing the possibility of tumor escape and enabling effective tumor cell killing Unlike other cellular therapies, MARKER’S MAR-T cell
  • Marker Therapeutics Announces First Patient Treated in Off-the-Shelf . . .
    About Marker Therapeutics, Inc Marker Therapeutics, Inc is a Houston, TX -based clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors
  • » 2019 » May » 21
    About Marker Therapeutics, Inc Marker Therapeutics, Inc is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications





中文字典-英文字典  2005-2009